Gano Kyle — SEC insider filings
SEC reporting owner CIK 1567160. 26 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2020-08-07 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 18 filings — 253,959 shares, $31,664,363 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 60.
- Largest priced transaction: sale of 68,884 shares @ $131.47 ($9,056,290) in NEUROCRINE BIOSCIENCES INC, filed 2024-01-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Executive Officer, Director | 26 | — | 34 legs · 253,959 sh · $31,664,363 | 60 |
Insider filings — Gano Kyle
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 614 @ $0 · Tax withholding (F): 332 @ $146.10 · Option exercise (M): 614 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 6,275 @ $0 · Tax withholding (F): 3,386 @ $156.22 · Grant/award (A): 1,842 @ $0 · Tax withholding (F): 994 @ $156.22 | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,907 @ $0 · Tax withholding (F): 2,648 @ $123.10 · Option exercise (M): 2,241 @ $0 · Tax withholding (F): 1,210 @ $124.12 · Option exercise (M): 2,566 @ $0 · Tax withholding (F): 1,385 @ $124.12 · +7 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,927 @ $0 · Tax withholding (F): 1,580 @ $136.06 · Option exercise (M): 2,927 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 34,588 @ $35.99 · Sale (S): 34,588 @ $132.70 · Option exercise (M): 1,812 @ $35.99 · Sale (S): 1,812 @ $132.71 · Option exercise (M): 34,588 (derivative) @ $0 · Option exercise (M): 1,812 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 613 @ $0 · Sale (S): 300 @ $141.97 · Option exercise (M): 613 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,566 @ $0 · Sale (S): 1,352 @ $116.84 · Option exercise (M): 2,241 @ $0 · Sale (S): 1,206 @ $116.86 · Grant/award (A): 104,736 (derivative) @ $0 · Grant/award (A): 19,628 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,860 @ $0 · Sale (S): 980 @ $118.39 · Option exercise (M): 1,860 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,927 @ $0 · Sale (S): 1,541 @ $152.87 · Option exercise (M): 2,927 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,812 @ $32.99 · Sale (S): 4,812 @ $141.50 · Option exercise (M): 60,188 @ $32.99 · Sale (S): 60,188 @ $141.50 · Option exercise (M): 4,812 (derivative) @ $0 · Option exercise (M): 60,188 (derivative) @ $0 | EDGAR |
| 2024-11-01 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 2,455 (derivative) @ $0 · Grant/award (A): 13,344 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,352 @ $132.89 · Grant/award (A): 45,058 (derivative) @ $0 · Grant/award (A): 8,966 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,600 @ $142.20 · Sale (S): 980 @ $134.20 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,541 @ $140.70 | EDGAR |
| 2024-01-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 68,884 @ $19.59 · Sale (S): 68,884 @ $131.47 · Option exercise (M): 6,116 @ $19.59 · Sale (S): 6,116 @ $131.44 · Option exercise (M): 68,884 (derivative) @ $19.59 · Option exercise (M): 6,116 (derivative) @ $19.59 | EDGAR |
| 2023-08-23 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,132 @ $107.41 | EDGAR |
| 2023-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 63,789 (derivative) @ $0 · Grant/award (A): 10,264 (derivative) @ $0 | EDGAR |
| 2023-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,600 @ $105.64 · Sale (S): 1,623 @ $102.29 · Sale (S): 12,801 @ $102.41 · Sale (S): 980 @ $103.99 | EDGAR |
| 2023-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,541 @ $109.98 | EDGAR |
| 2022-02-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 703 @ $80.68 · Sale (S): 1,974 @ $80.80 · Sale (S): 1,623 @ $80.78 · Sale (S): 1,600 @ $80.77 · Sale (S): 980 @ $79.67 | EDGAR |
| 2022-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 79,720 (derivative) @ $0 · Grant/award (A): 11,706 (derivative) @ $0 | EDGAR |
| 2022-01-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 28,266 @ $8.66 · Sale (S): 28,266 @ $85.50 · Option exercise (M): 28,266 (derivative) @ $8.66 | EDGAR |
| 2021-03-29 | 4/A | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 49,049 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 703 @ $113.77 · Sale (S): 1,974 @ $114.09 · Sale (S): 1,070 @ $116.89 · Sale (S): 1,000 @ $116.83 · Sale (S): 1,623 @ $116.83 · Grant/award (A): 44,632 (derivative) @ $0 · +1 more | EDGAR |
| 2020-11-16 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,257 @ $90.73 | EDGAR |
| 2020-08-07 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 2,257 @ $118.87 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1567160 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs